A Recipe for Growth in Food Allergy Prevention
At the intersection of consumer and healthcare, food allergies have a massive addressable market—but plenty of complexities investors should consider
Sectors
All Eyes on the Presidential Race
M&A experts weigh in on how election outcomes might impact dealmaking in the months ahead
Betting on the Face Card: Building out Aesthetic Healthcare Brands
Investors and advisors tracking med spas say there is ample opportunity for expansion and building platforms in a highly fragmented market comprised of small clinics
The Risks and Rewards of Investing in Women’s Healthcare
A panel hosted by ACG Chicago discussed regulatory changes, emerging technology and other trends shaping the women’s health vertical
AI Bears Doubt Its Promise to Deliver
Proponents say artificial intelligence will revolutionize many industries, including M&A—but skeptics say this AI revolution may not materialize
How Private Equity Can Respond to Foreign Investment Risks
In light of recent warnings on the risks of foreign investments, PE and VC firms must remain vigilant and proactive in safeguarding the sensitive information of their portfolio companies
Consumer M&A Muddles Through Amid Mixed Spending Habits
Dealmakers take a wait-and-see approach to consumer M&A, even as inflation cools and interest rates drop
As Wallets Tighten, Food Industry Dealmakers Get Picky
Shifting consumer habits are driving change in food-related M&A, from the manufacturing plant to the dining booth
Closing the Gender Gap at Senior Levels of Financial Services
Despite progress on gender diversity, the financial services industry remains imbalanced at its most senior levels. Speakers discussed this challenge at the women’s networking breakfast during ACG’s DealMAX.
What’s Next for PE Firms: An SEC Update
Emilie Abate of Iron Road Partners shares her insights into how regulation of the private equity space is shaping up